Diabetes Mellitus and Associated Factors Among Adult HIV Patients on Highly Active Anti-Retroviral Treatment

References

• Ana RC, FLavia AM. A diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test; which method to choose for the diagnosis? BMC Infect Dis. 2018;18(309):1–13.29291713
   PubMedGoogle Scholar
• Quin J. Diabetes and HIV. Clin Med (Northfield Il). 2014;14(6):667–669. doi:10.7861/clinmedicine.14-6-667
   PubMed Web of Science ®Google Scholar
• WHO. Summary of the Global HIV Epidemic; 2018.
   Google Scholar
• Sanjay K, Bharti K, Navneet A, et al. Understanding diabetes in patients with HIV/AIDS. Diabetol Metab Syndr. 2011;3(2):1–7.21226946
   PubMedGoogle Scholar
• Tierney L, Mcphee S, Paladakis M, et al. Current Medical Diagnosis and Treatment. International Edition. New York: Lange medical Books/McGraw-Hill; 2002:203–215.
   Google Scholar
• Shih P, Chun Y. Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy a nationwide population-based study. Medicine. 2018;97(36):1–7.
   Web of Science ®Google Scholar
• Chhoun P, Ngin C, Tuot S, et al. Non-communicable diseases and related risk behaviors among men and women living with HIV in Cambodia: findings from a cross-sectional study. Int J Equity Health. 2017;16(125):1–12. doi:10.1186/s12939-017-0622-y28057005
   PubMedGoogle Scholar
• Temesgen F, Alemu G. Diabetes mellitus and its associated factors among human immunodeficiency virus-infected patients on anti-retroviral therapy in Northeast Ethiopia. BMC Res Notes. 2019;12(372):1–7.30602384
   PubMedGoogle Scholar
• Andrew C, David AC. Adverse effects of antiretroviral therapy. Lancet. 2000;356:1423–1429.11052597
   PubMed Web of Science ®Google Scholar
• Anne K, Marshall J, Todd TB, et al. Diagnosing and managing diabetes in HIV-infected patients: current concepts. Clin Infect Dis. 2015;60(3):453–462. doi:10.1093/cid/ciu77925313249
   PubMedGoogle Scholar
• Avari P, Devendra S. Human immunodeficiency virus and type 2 diabetes. London J Prim Care. 2017;9(3):38–42. doi:10.1080/17571472.2017.1302872
   PubMed Web of Science ®Google Scholar
• André PS, Anderson MN, Andiara S. Lipodystrophy diagnosis in people living with HIV/AIDS: prediction and validation of sex-specific anthropometric models. BMC Public Health. 2018;18(806):1–14.
   Google Scholar
• Emile CN, Jean CK, Eugene S, et al. Diabetes and HIV. Curr Diab. 2018;18(125):1–8.
   PubMedGoogle Scholar
• Aboud M, Elgalib A, Kulasegaram R, et al. Insulin resistance and HIV infection: a review. Int clin Pract. 2007;61(3):1463–1472.
   Web of Science ®Google Scholar
• Carl A, Copper D. Adverse effect of antiretroviral therapy. Lancet. 2000;356(9239):1423–1430. doi:10.1016/S0140-6736(00)02854-311052597
   PubMedGoogle Scholar
• Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;6(1):48–62. doi:10.1056/NEJMra041811
   Web of Science ®Google Scholar
• Kalra S, Agrawal N. Diabetes and HIV: current understanding and future perspectives. Curr Diab Rep. 2013;13(3):419–427. doi:10.1007/s11892-013-0369-923446780
   PubMed Web of Science ®Google Scholar
• Behrens G, Stoll M, Schmidt R, et al. Lipodystrophy syndrome in HIV infection. What is it, what causes it and how can it be managed? Off J Int Soc Pharmacovigilance. 2000;23(1):57–76.
   Google Scholar
• Maganga E, Smart L, Kalluvya S, et al. Glucose metabolism disorders, HIV and antiretroviral therapy among Tanzanian adults. PLoS One. 2015;10(8):1–10. doi:10.1371/journal.pone.0134410
   Web of Science ®Google Scholar
• Jerico C, Knobel H, Montero M, et al. Metabolic syndrome among HIV-infected patients: prevalence, characteristics and related factors. Diabetes Care. 2005;28(1):132–137. doi:10.2337/diacare.28.1.13215616246
   PubMedGoogle Scholar
• Miller J, Carr A, Emery S, et al. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Med. 2003;4(3):293–301. doi:10.1046/j.1468-1293.2003.00159.x12859330
   PubMedGoogle Scholar
• Assane D, Amandine C, Khadidiatou B, et al. Diabetes and hypertension among patients receiving antiretroviral treatment since 1998 in Senegal. Int Sch Res Network. 2012;1–8.
   Google Scholar
• Hejazi N, Rajikan R, Choong C, et al. Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey. BMC Public Health. 2013;13(1):1–11. doi:10.1186/1471-2458-13-75823280303
   PubMedGoogle Scholar
• Movahed E, Ali M, Farokhzadain J, et al. Antiretroviral therapy adherence among people living with HIV: directed content analysis based on information-motivation-behavioral skills model. Int Q Community Health Educ. 2019;40(1):1–9.
   Web of Science ®Google Scholar
• CDC. National Health and Nutrition Examination Survey (NHANES). Anthropometry Procedures Manual; 2007.
   Google Scholar
• Zerihun A, Wondimye A. Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV‑positive individuals receiving highly active antiretroviral therapy at Jugal Hospital, Harar, Ethiopia. HIV AIDS (Auckl). 2018;10:181–192. doi:10.2147/HIV.S17687730349400
   PubMedGoogle Scholar
• Sheila K, Doris M. Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, Uganda. PLoS One. 2019;14(8):1–11.
   Web of Science ®Google Scholar
• Alemu G, Bekele T. Diabetes mellitus and its associated risk factors in patients with human immunodeficiency virus on anti-retroviral therapy at referral hospitals of North West Ethiopia. Diabetol Metab Syndr. 2020;12(20):1–8.31921358
   PubMedGoogle Scholar
• Adeel A, Kathleen M. HIV infection and the risk of diabetes mellitus. AIDS. 2009;23:1227–1234. doi:10.1097/QAD.0b013e32832bd7af19444074
   PubMedGoogle Scholar
• Solomon M, Assefa G. Diabetes mellitus among HIV-infected individuals in follow-up care at University of Gondar Hospital, North west Ethiopia. BMJ. 2016;6:1–6.
   Web of Science ®Google Scholar
• Win M, Awachana J, Sasisopin K, et al. Diabetes mellitus burden among people living with HIV from the Asia-Pacific region. J Int AIDS Soc. 2019;22:1–8.
   Web of Science ®Google Scholar
• Moyo D, Tanthuma G, Mushisha O, et al. Diabetes mellitus in HIV-infected patients receiving antiretroviral therapy. S Afr Med J. 2014;104(1):37–39. doi:10.7196/samj.6792
   Web of Science ®Google Scholar